HR 'Significantly Better Than Expected' In Akeso's HARMONi-2 Trial in 1L NSCLC

Head-To-Head Study With Keytruda

 
• By Dexter Jie Yan
  
speculation
New disclosures heighten discussion of clinical meaningfulness of Akeso's head-to-head trial with Keytruda • Source: Shutterstock

More from China

More from Focus On Asia